Societe D'etudes Scientifiques Et Industrielles De L'ile-de-france

Laboratoires Delagrange (synthelabo)

Laboratoires Delagrange Div. Societe D'applications Pharmacodynamiques

Laboratoires Delagrange Societe D'application Pharmacodynamiques

Laboratoires Delagrange Societe D'applications Pharmacodnymiques

Renee Gardaix-Luthereau

Jacques Acher

Jean-Claude Monier

Brenda Costall

Robert J Naylor

Jean-Paul Schmitt

Jacqueline F Franceschini

Josette Margarit

Anxiolytic and antipsychotic treatment is provided to patients by administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-imidazolyl)-ami no]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof.

Method of providing anxiolytic and antipsychotic treatment

The present invention relates to the use of substituted benzamides of formula (1): ##STR1## in which: A is linear or branched C.sub.1 -C.sub.3 alkyl; allyl or diethylaminoethyl;

Method of increasing gastrointestinal motility with substituted

Anxiolytic and antipsychotic treatment is provided to patients by administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-immidazolyl)-am ino]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof.

The invention relates to the use of benzamide derivatives of the formula: ##STR1## in which: A is a diethylaminoethyl group or a group of the formula II: ##STR2## where R is a C.sub.1 -C.sub.3 alkyl, allyl, cyclopropylmethyl or cyclohexenylmethyl group,

Method of treating disorders of cognitive function with substituted

The present invention relates to the application of substituted benzamides of formula (I): ##STR1## in which: A is diethylaminoethyl, 1-ethyl-2-pyrrolidinylmethyl or 1-allyl-2-pyrrolidinylmethyl;

Method of providing anxiolytic and antipsychotic treatment with

New substituted benzamides have the general formula: ##STR1## A=alkyl, alkenyl, diethylaminoethyl or ##STR2## R.sub.1, R.sub.2 =H, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl; R.sub.3, R.sub.4, R.sub.5, R.sub.6 =hydrogen or C.sub.1 -C.sub.6 alkyl;

Novel benzamides, intermediates and process for the preparation and

The invention concerns novel benzamides and their pharmacologically acceptable salts which are useful as gastromotor agents and correspond to the following general formula (I): ##STR1## in which: R.sub.1 is lower alkyl, lower alkenyl or a hydrogen atom;

Growing community of inventors

Cachan, France

Renee Gardaix-Luthereau